14-70458715-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003813.4(ADAM21):āc.1216C>Gā(p.Leu406Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,880 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_003813.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAM21 | NM_003813.4 | c.1216C>G | p.Leu406Val | missense_variant | 2/2 | ENST00000603540.2 | NP_003804.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAM21 | ENST00000603540.2 | c.1216C>G | p.Leu406Val | missense_variant | 2/2 | 3 | NM_003813.4 | ENSP00000474385 | P1 | |
ENST00000556646.1 | n.184-5206G>C | intron_variant, non_coding_transcript_variant | 4 | |||||||
ADAM20P1 | ENST00000649019.1 | n.506+1735G>C | intron_variant, non_coding_transcript_variant | |||||||
ADAM21 | ENST00000679631.1 | c.1216C>G | p.Leu406Val | missense_variant | 2/2 | ENSP00000506213 | P1 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461880Hom.: 0 Cov.: 37 AF XY: 0.00000138 AC XY: 1AN XY: 727246
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 29, 2023 | The c.1216C>G (p.L406V) alteration is located in exon 2 (coding exon 1) of the ADAM21 gene. This alteration results from a C to G substitution at nucleotide position 1216, causing the leucine (L) at amino acid position 406 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.